GENENTECH INC FDA Approval BLA 761053

BLA 761053

GENENTECH INC

FDA Drug Application

Application #761053

Documents

Label2017-03-30
Medication Guide2017-03-30
Letter2017-03-30
Review2017-05-09
Label2018-11-23
Letter2018-11-15
Label2019-07-17
Letter2019-07-18
Letter2020-01-14
Label2020-01-14
Medication Guide2020-01-14
Label2020-05-19
Medication Guide2020-05-26
Letter2020-11-10
Label2020-11-10
Medication Guide2020-11-12
Label2020-12-14
Letter2020-12-15
Letter2022-08-04
Letter2022-08-04
Label2022-08-05
Label2022-08-05
Medication Guide2022-08-05

Application Sponsors

BLA 761053GENENTECH INC

Marketing Status

Prescription001

Application Products

001INJECTABLE;INJECTION30MG/1ML0OCREVUSOCRELIZUMAB

FDA Submissions

TYPE 1; Type 1 - New Molecular EntityORIG1AP2017-03-28PRIORITY
LABELING; LabelingSUPPL8AP2017-11-02STANDARD
LABELING; LabelingSUPPL12AP2018-11-12STANDARD
LABELING; LabelingSUPPL18AP2019-07-16STANDARD
LABELING; LabelingSUPPL20AP2020-01-10STANDARD
EFFICACY; EfficacySUPPL22AP2020-12-14STANDARD
LABELING; LabelingSUPPL23AP2020-11-06STANDARD
LABELING; LabelingSUPPL24AP2020-05-15STANDARD
LABELING; LabelingSUPPL29AP2022-08-03STANDARD
LABELING; LabelingSUPPL30AP2022-08-03STANDARD

Submissions Property Types

ORIG1Null6
SUPPL8Null7
SUPPL12Null6
SUPPL18Null7
SUPPL20Null7
SUPPL22Null15
SUPPL23Null7
SUPPL24Null15
SUPPL29Null7
SUPPL30Null46

CDER Filings

GENENTECH INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 761053
            [companyName] => GENENTECH INC
            [docInserts] => ["Medication Guide","https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2020\/761053s024lbl.pdf#page=18"]
            [products] => [{"drugName":"OCREVUS","activeIngredients":"OCRELIZUMAB","strength":"30MG\/1ML","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"None","rld":"No","rs":"No"}]
            [labels] => [{"actionDate":"05\/15\/2020","submission":"SUPPL-24","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2020\\\/761053s024lbl.pdf\"}]","notes":""},{"actionDate":"01\/10\/2020","submission":"SUPPL-20","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2020\\\/761053s020lbl.pdf\"}]","notes":""},{"actionDate":"07\/16\/2019","submission":"SUPPL-18","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/761053s018lbl.pdf\"}]","notes":""},{"actionDate":"11\/12\/2018","submission":"SUPPL-12","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2018\\\/761053s012lbl.pdf\"}]","notes":""},{"actionDate":"03\/28\/2017","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2017\\\/761053lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"03\/28\/2017","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"N\/A","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2017\\\/761053lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2017\\\/761053Orig1s000ltr.pdf\"},{\"name\":\"Review\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/nda\\\/2017\\\/761053Orig1s000TOC.cfm\"}]","notes":">"}]
            [supplements] => [{"actionDate":"05\/15\/2020","submission":"SUPPL-24","supplementCategories":"Supplement","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2020\\\/761053s024lbl.pdf\"}]","notes":">"},{"actionDate":"01\/10\/2020","submission":"SUPPL-20","supplementCategories":"Supplement","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2020\\\/761053s020lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2020\\\/761053Orig1s020ltr.pdf\"}]","notes":">"},{"actionDate":"07\/16\/2019","submission":"SUPPL-18","supplementCategories":"Supplement","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/761053s018lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2019\\\/761053Orig1s018ltr.pdf\"}]","notes":">"},{"actionDate":"11\/12\/2018","submission":"SUPPL-12","supplementCategories":"Supplement","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2018\\\/761053s012lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2018\\\/761053Orig1s012ltr.pdf\"}]","notes":">"},{"actionDate":"11\/02\/2017","submission":"SUPPL-8","supplementCategories":"Supplement","inserts":"[]","notes":"> Label is not available on this site."}]
            [actionDate] => 2020-05-15
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.